Aerovate Therapeutics Inc...

2.44
0.02 (0.83%)
At close: Feb 28, 2025, 3:59 PM
2.43
-0.21%
After-hours: Feb 28, 2025, 04:00 PM EST

Aerovate Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 96K 68K 15K 1K n/a
Gross Profit -96K -68K -15K -1K n/a
Operating Income -81.41M -53.24M -23.02M -8.89M -3.33M
Interest Income 5.95M 1.83M 65K 75.00 n/a
Pretax Income -75.47M -51.49M -22.96M -9.61M -3.33M
Net Income -75.52M -51.51M -22.96M -9.04M -3.33M
Selling & General & Admin 17.19M 14.62M 8.04M 949K 218K
Research & Development 64.22M 38.62M 14.99M 7.94M 3.11M
Other Expenses 0.00 -79K -3K -647K 1K
Operating Expenses 81.41M 53.24M 23.02M 8.89M 3.33M
Interest Expense n/a n/a 65K 75K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 81.41M 53.24M 23.02M 8.89M 3.33M
Income Tax 56K 25K 3K -572K 1K
Shares Outstanding (Basic) 26.33M 24.47M 24.41M 24.41M 24.41M
Shares Outstanding (Diluted) 26.33M 24.47M 24.41M 24.41M 24.41M
EPS (Basic) -2.87 -2.1 -0.94 -0.37 -0.14
EPS (Diluted) -2.87 -2.1 -0.94 -0.37 -0.14
EBITDA -81.31M -53.17M -23.01M -8.89M 1K
Depreciation & Amortization 96K 68K 15K 1K 3.33M